PCN214 – Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing
Reads0
Chats0
TLDR
Although there are many issues to overcome to adopt NGS, the likelihood of NGS incorporation in clinical practice is very high and the “additional future information” is the most interesting but complex variable to identify and to incorporate in cost-effectiveness modeling.About:
This article is published in Value in Health.The article was published on 2014-11-01 and is currently open access. It has received 2 citations till now. The article focuses on the topics: Expert elicitation & Cost effectiveness.read more
Citations
More filters
Journal ArticleDOI
Early Assessment of Innovation in a Healthcare Setting
TL;DR: Although this review has identified applicable approaches for early assessment in different innovation stages, research is required regarding the value of the available data and methods and tools to enhance interactions between different parties at different stages of innovation.
Journal ArticleDOI
A Web-Based Communication Platform to Improve Home Care Services in Norway (DigiHelse): Pilot Study
TL;DR: Interestingly, behavioral data from the digital platform revealed that only 3.55% (121/3405) of recipients actively used the platform after one year, suggesting the low adoption rate may explain the inability of DigiHelse to perform as expected.
Related Papers (5)
Scenario drafting for early technology assessment of next generation sequencing in clinical oncology
Health Care Infrastructure for Financially Sustainable Clinical Genomics.
Jochen K. Lennerz,Heather M. McLaughlin,Jason M. Baron,David A. Rasmussen,Meini Sumbada Shin,Nancy Berners-Lee,Julie M. Batten,Kathryn J. Swoboda,Manish Gala,Harland S. Winter,Jeremy D. Schmahmann,David A. Sweetser,Marianne Boswell,Maciej Pacula,Albrecht Stenzinger,Long P. Le,William M. Hynes,Heidi L. Rehm,Anne Klibanski,Stephen Black-Schaffer,Jeffrey A. Golden,David N. Louis,Scott T. Weiss,A. John Iafrate +23 more